{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:21:20Z","timestamp":1761740480194,"version":"3.37.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,27]]},"DOI":"10.1097\/tp.0b013e31819ebf76","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T21:08:42Z","timestamp":1242940122000},"page":"1180-1190","source":"Crossref","is-referenced-by-count":15,"title":["Increasing Utilization of Human T-Cell Lymphotropic Virus (+) Donors in Liver Transplantation: Is it Safe?"],"prefix":"10.1097","volume":"87","author":[{"given":"Michael R.","family":"Marvin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy N.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwadwo","family":"Kwarteng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Nagubandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadiyala V.","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Buell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation.","volume":"5","author":"Merion","year":"2006","journal-title":"Am J Transplant"},{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1478-3231.2008.01831.x","article-title":"Pretransplant variables associated with quality of life in liver transplant recipients.","volume":"28","author":"Saab","year":"2008","journal-title":"Liver Int"},{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/294268a0","article-title":"Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia.","volume":"294","author":"Popovic","year":"1981","journal-title":"Nature"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity.","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1034\/j.1600-6143.2002.20712.x","article-title":"Human T-cell lymphotrophic virus infection in organ donors: A need to reassess policy?","volume":"2","author":"Shames","year":"2002","journal-title":"Am J Transplant"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.TP.0000058470.15921.CA","article-title":"Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor.","volume":"75","author":"Gonzalez-Perez","year":"2003","journal-title":"Transplantation"},{"key":"R7-13-20210129","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/jnnp.71.6.818","article-title":"Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant.","volume":"71","author":"Zarranz","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-13-20210129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00007890-200301150-00019","article-title":"Rapid development of subacute myelopathy in three organ transplant recipeints after transmission of human T-cell lymphotropic virus type I from a single donor.","volume":"75","author":"Toro","year":"2003","journal-title":"Transplantation"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers.","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"year":"2003","author":"Klein","article-title":"Survival Analysis. 2nd ed.","key":"R11-13-20210129"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion).","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Stat Soc B"},{"key":"R13-13-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of change point methods in studying the effect of age on survival in breast cancer.","volume":"30","author":"Contal","year":"1999","journal-title":"Comput Stat Data Anal"},{"key":"R14-13-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","article-title":"The HTLV-1 neurological complex.","volume":"5","author":"Araujo","year":"2006","journal-title":"Lancet Neurol"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1038\/sj.onc.1208971","article-title":"Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.","volume":"24","author":"Feurer","year":"2005","journal-title":"Oncogene"},{"key":"R16-13-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.20126","article-title":"Human T-lymphotropic virus type II and neurological disease.","volume":"56","author":"Araujo","year":"2004","journal-title":"Ann Neurol"},{"key":"R17-13-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199304223281608","article-title":"Pathogenesis of diseases induced by human lymphotrophic virus type I infection.","volume":"328","author":"Holsberg","year":"1993","journal-title":"N Engl J Med"},{"key":"R18-13-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.284.2.229","article-title":"Trends in the incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991\u201396.","volume":"284","author":"Glynn","year":"2000","journal-title":"JAMA"},{"key":"R19-13-20210129","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<662::AID-IJC5>3.0.CO;2-I","article-title":"A study of adult T-cell leukemia\/lymphoma incidence in central Brooklyn.","volume":"80","author":"Levine","year":"1999","journal-title":"Int J Cancer"},{"key":"R20-13-20210129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00042560-199504120-00006","article-title":"Clinical spectrum of HTLV-I in south Florida.","volume":"8","author":"Harrington","year":"1995","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-13-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0925-5710(97)00077-7","article-title":"HTLV-1 associated diseases.","volume":"63","author":"Watanabe","year":"1997","journal-title":"Int J Hematol"},{"key":"R22-13-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","article-title":"Incidence of HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad.","volume":"17","author":"Maloney","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R23-13-20210129","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","article-title":"Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study.","volume":"63","author":"Olindo","year":"2006","journal-title":"Arch Neurol"},{"key":"R24-13-20210129","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/S0041-1345(98)00980-4","article-title":"Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients.","volume":"30","author":"Tanabe","year":"1998","journal-title":"Transplant Proc"},{"key":"R25-13-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.tp.0000235186.30113.c7","article-title":"Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation.","volume":"82","author":"Kawano","year":"2006","journal-title":"Transplantation"},{"key":"R26-13-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/lt.21414","article-title":"Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation.","volume":"14","author":"Soyama","year":"2008","journal-title":"Liver Transpl"},{"key":"R27-13-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-510X(00)00332-4","article-title":"HTLV-I associated myelopathy manifested after renal transplantation.","volume":"177","author":"Nakatsuji","year":"2000","journal-title":"J Neurol Sci"},{"key":"R28-13-20210129","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/01.TP.0000071847.36786.C1","article-title":"Human T-cell lymphotrophic virus type-1 and organ donors.","volume":"76","author":"Kauffman","year":"2003","journal-title":"Transplantation"},{"key":"R31-13-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1086\/510679","article-title":"Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy\/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.","volume":"44","author":"Silva","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"S2","key":"R32-13-20210129","first-page":"231","article-title":"Optimal utilization of HTLV I\/II positive organs\u2014A nationwide survey.","volume":"8","author":"Nagubandi","year":"2008","journal-title":"Am J Trans"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200904270-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:48:47Z","timestamp":1739119727000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200904270-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,27]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31819ebf76","relation":{},"ISSN":["0041-1337"],"issn-type":[{"type":"print","value":"0041-1337"}],"subject":[],"published":{"date-parts":[[2009,4,27]]}}}